Strategic Advances Reshaping the Global Bio Pharma Buffer Market
The emergence of cell and gene therapies (CGTs) has introduced an entirely new paradigm into the healthcare sector, moving away from managing chronic conditions toward providing potential cures for rare genetic disorders. These advanced therapies rely on complex biological vectors, such as adeno-associated viruses (AAVs) and lentiviruses, as well as live cellular inputs like CAR-T cells....
0 Commenti 0 condivisioni 272 Views 0 Anteprima